Thrombocytopenia as Type 1 ROP Biomarker: A Longitudinal Study
暂无分享,去创建一个
A. Fantin | S. Salvadori | Luisa Frizziero | R. Parrozzani | Giulia Marchione | D. Nardo | Giulia Midena | G. Midena | L. Frizziero | G. Marchione
[1] Lois E. H. Smith,et al. Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP , 2021, Neonatology.
[2] S. Salvadori,et al. Severe retinopathy of prematurity is associated with early post-natal low platelet count , 2021, Scientific reports.
[3] W. Kuliczkowski,et al. Platelet polyphosphate level is elevated in patients with chronic primary thrombocytopenia: A preliminary study. , 2020, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[4] R. Flaumenhaft,et al. Megakaryocytes package contents into separate α-granules that are differentially distributed in platelets. , 2019, Blood advances.
[5] A. Razak,et al. Association of small for gestational age with retinopathy of prematurity: a systematic review and meta-analysis , 2019, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[6] Ji Woong Chang. Risk factor analysis for the development and progression of retinopathy of prematurity , 2019, PloS one.
[7] C. Gilbert,et al. Epidemiology of ROP update - Africa is the new frontier. , 2019, Seminars in perinatology.
[8] Lois E. H. Smith,et al. Thrombocytopenia is associated with severe retinopathy of prematurity. , 2018, JCI insight.
[9] Lois E. H. Smith,et al. Erythropoietin serum levels, versus anaemia as risk factors for severe retinopathy of prematurity , 2018, Pediatric Research.
[10] K. Taylor,et al. The genetics of retinopathy of prematurity: a model for neovascular retinal disease. , 2018, Ophthalmology. Retina.
[11] Ryan Swan,et al. Retinopathy of prematurity: a review of risk factors and their clinical significance. , 2018, Survey of ophthalmology.
[12] J. Geisel,et al. Nucleated red blood cells and serum lactate values on days 2 and 5 are associated with mortality and morbidity in VLBW infants , 2018, Wiener Medizinische Wochenschrift.
[13] Jiayan Huang,et al. Longitudinal study of the association between thrombocytopenia and retinopathy of prematurity. , 2018, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[14] M. Akın,et al. Platelet mass index can be a reliable marker in predicting the prognosis of retinopathy of prematurity in very preterm infants. , 2017, Pediatrics and neonatology.
[15] A. L. Solebo,et al. Epidemiology of blindness in children , 2017, Archives of Disease in Childhood.
[16] C. Bunce,et al. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk , 2017, BMJ Open.
[17] R. Bercovitz,et al. Neonatal Platelet Transfusions and Future Areas of Research. , 2016, Transfusion medicine reviews.
[18] Lois E. H. Smith,et al. Aggressive Posterior Retinopathy of Prematurity Is Associated with Multiple Infectious Episodes and Thrombocytopenia , 2016, Neonatology.
[19] R. Christensen,et al. Thrombocytopenia in Small-for-Gestational-Age Infants , 2015, Pediatrics.
[20] Gabrielle Lapping-Carr,et al. Neonatal Thrombocytopenia: Etiology and Diagnosis. , 2015, Pediatric annals.
[21] M. Hartnett,et al. Mechanisms and management of retinopathy of prematurity. , 2012, The New England journal of medicine.
[22] Gui-Shuang Ying,et al. Thrombocytopenia and retinopathy of prematurity. , 2011, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[23] G. Quinn,et al. Retinopathy of prematurity: an epidemic in the making. , 2010, Chinese medical journal.
[24] Anand Vinekar,et al. DO PLATELETS HAVE A ROLE IN THE PATHOGENESIS OF AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY? , 2010, Retina.
[25] J. Folkman,et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.
[26] J. Folkman. Opinion: Angiogenesis: an organizing principle for drug discovery? , 2007, Nature Reviews Drug Discovery.
[27] Anna L. Ells,et al. The International Classification of Retinopathy of Prematurity revisited. , 2005, Archives of ophthalmology.
[28] W. Tasman,et al. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. , 2004, Archives of ophthalmology.
[29] W. Fierson,et al. Screening Examination of Premature Infants for Retinopathy of Prematurity , 1997, Pediatrics.
[30] J. Stone,et al. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. , 1996, Investigative ophthalmology & visual science.
[31] B. Brüne,et al. Receptor occupancy regulates Ca2+ entry and intracellular Ca2+ redistribution in activated human platelets. , 1994, The Biochemical journal.
[32] N. Ashton,et al. Effect of Oxygen on Developing Retinal Vessels with Particular Reference to the Problem of Retrolental Fibroplasia , 1954, The British journal of ophthalmology.
[33] F. Ovalı,et al. THROMBOCYTOPENIA AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY , 2019, Retina.
[34] J. Flynn,et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. , 1992, The New England journal of medicine.